Global Investor Forum Contact

Danielle Curfs

Manager InSciTe Biomedical Program, Chemelot InSciTe

Session

11:30 - 12:45 hours
From innovation to implementation

Daniëlle studied Environmental Health Sciences at the University of Maastricht. After obtaining her PhD on the topic of Environmental Carcinogens and Atherogenesis in 2005, she started working as a research fellow in a public-private partnership (UM, Organon, SenterNovem) on the development of fast screening methods for target genes in atherosclerosis and the role of macrophages in inflammation and atherosclerosis.
In 2009 she transferred to the BioMedical Materials (BMM) program, a Dutch public private partnership. Here she worked as program coordinator for the cardiovascular, nephrology and drug delivery projects. Moreover, she fulfilled the role of communications manager for BMM.
In 2013 her activities moved to the DSM Innovation Center where she combined the role of project director of DSM’s Science & Technology platform Health with the setup of Chemelot InSciTe. As of 2015 Danielle is fulltime heading InSciTe’s Biomedical program where she developed the Biomedical Accelerator Matrix concept.

Abstract

How to Accelerate from patent to patient
Too many lab-proven (medical) concepts never reach the patient. The (Bio)medical Accelerator Matrix was developed to increase the chances of success. The Matrix provides a work-learning environment with the necessary infrastructural, technical and quality elements crucial in the translation and acceleration of concepts to patients. Via a plug and play service menu clients, being it companies or entrepreneurial academics, choose those elements they need to develop their lab-proven concept to first-in-man.

Kees Been
Lysosomal Therapeutics Inc.

Erik van de Berg
AM-Pharma

René Bernards
Qameleon Therapeutics & NKI

Annelien Bredenoord
UMC Utrecht

Carine van den Brink
AXON Lawyers

Danielle Curfs
Chemelot InSciTe
Jenny Dankelman
TU Delft
Diederik Dippel
Erasmus MC

Cornelia van Duijn
Erasmus MC

Lude Franke
UMCG
Thibault Helleputte
DNAlytics
Mark van Houdenhoven
St. Maartenskliniek
Henk Joos
Flanders Bio
Peter de Keizer
Erasmus MC
Tim Knotnerus
AM-Pharma, PRIMER Professionals
Angus Livingstone
Oncode Institute
Travis McCready
Massachusetts Life Sciences Center

Mirjam Mol
Pivot Park

Barend Mons
DTL & LUMC
Timothy Noël
Eindhoven University of Technology
Jacquelien Noordhoek
Dutch CF Foundation
Violet Petit-Steeghs
Athena Institute
Thomas Plochg
NPHF
Dirk Jan van der Pol
Ordina
Anne Portwich
LSP
Elisabeth van Rossum
Erasmus MC
André van de Sande
Xendo
Marlies Schijven
AMC
Hans Schikan
Topsector LSH
Hanneke Schuitemaker
Janssen Vaccines
Frits Schut
V.O. Patents & Trademarks
Marieke Schuurmans
UMC Utrecht
Jacob Seidell
VU
Agaath Sluijter
Medical Delta
Thijs Spigt
Erasmus MC
Marianne van der Steen
Maastricht University
Maarten Steinbuch
Eindhoven University of Technology
Onno van de Stolpe
Galapagos
Werner Verbiest
Janssen Diagnostics
Martine de Vries
LUMC

Edward van Wezel
BioGeneration Ventures

Jan van de Winkel
Genmab

Loek Winter
DC Klinieken

Hanneke Heeres
Health~Holland
Caroline Duterloo
Medical Delta
Paul Korte
Janssen
Aart Jan van der Lelij
Erasmus MC
Werner Brouwer
Erasmus University
Arnout van Diermen
Novo Nordisk

Ton van der Steen
Erasmus MC & Medical Delta

Sponsors & Partners
Main partner
Host sponsor
Host sponsor
Host sponsor
Platinum sponsor
Platinum sponsor
Platinum sponsor
Platinum sponsor
Gold sponsor
Silver sponsor
Award sponsor
Award sponsor
© 2018 Innovation for Health